ArticleJournal of patient experience2025
Impact of COVID-19 Pandemic on the Management of Oncology Patients in Eastern Canada.
Article in Journal of patient experience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study assessed the impact of the COVID-19 pandemic on adult oncology patients at an oncology clinic in Atlantic Canada. Patients completed a survey about their cancer diagnosis, treatment, and the impact of the COVID-19 pandemic on their health between September 2021 and April 2022. Seroprotection from the COVID-19 vaccine was assessed in a subset of patients. Of the 178 patients who provided consent, 161 completed the survey and 134 provided blood samples for seropositive analysis. Most reported no perceived delays in their cancer diagnosis (93.2%), treatment (91.8%), or follow-up care (98.1%) because of the pandemic. Although 75.2% of patients reported anxiety about contracting COVID-19, majority (96.3%) did not miss their appointments because of the pandemic. Seroprotection rates after COVID-19 vaccination did not differ significantly by treatment type; however, patients with hematological cancers had a significantly lower response. This study offers a snapshot of how the COVID-19 pandemic affected the diagnosis, treatment, and well-being of patients with cancer. The findings may help to guide clinical decisions and mitigate care delays in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.